Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X Shares

144.69
+4.693.35%
Pre-market: 146.401.71+1.18%05:03 EDT
Volume:67.72K
Turnover:9.80M
Market Cap:202.57M
PE:- -
High:147.00
Open:138.48
Low:138.48
Close:140.00
52wk High:150.00
52wk Low:74.34
Shares:1.40M
Float Shares:1.40M
Volume Ratio:0.89
T/O Rate:4.84%
Dividend:1.26
Dividend Rate:0.87%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lilly Stock Jumps on Strong GLP-1 Sales

Dow Jones
·
Aug 05

Eli Lilly CFO Says Injectable Glp-1 Drugs Remain Key Growth Driver, Account for Three Out of Four New Patient Starts: Conf Call

THOMSON REUTERS
·
Aug 05

Eli Lilly Shares Surge Nearly 6% at Market Open

Deep News
·
Aug 05

Eli Lilly Lifts Annual Revenue Forecast After Blockbuster Drug Sales Surge Overseas

Deep News
·
Aug 05

Eli Lilly and Company Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Sector Update: Healthcare

MT Newswires Live
·
Aug 05

Eli Lilly Posts Q2 Revenue Growth Driven by Soaring GLP-1 Drug Demand

Deep News
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

U.S. Stocks on the MOVE-Arista Networks, CVS, Eli Lilly, Phillips 66

Reuters
·
Aug 05

US Stocks-S&P 500, Dow Futures Inch up as Mideast Hopes Offset SpaceX, AMD Drag

Reuters
·
Aug 05

Eli Lilly's second-quarter revenue hits $22.97 billion, surpassing expectations of $20.59 billion

Deep News
·
Aug 05

Eli Lilly's stock surges 6% in pre-market trading after strong Q2 earnings beat

Deep News
·
Aug 05

Weight Loss Drug Demand Surges, Eli Lilly's Q2 Revenue Soars 48% Year-Over-Year, Full-Year Guidance Raised to $85-87 Billion | Earnings Report

Deep News
·
Aug 05

Lilly's Revenue Soars 48%, Driven by Demand of Its GLP-1s

Dow Jones
·
Aug 05

Lilly Q2 Adjusted EPS USD 8.38 Vs. IBES Estimate USD 6.01

Reuters
·
Aug 05

Lilly Q2 2026 Earnings: Mounjaro and Zepbound Drive 48% Revenue Growth

TradingKey
·
Aug 05

Lilly Beats Estimates on Resilient Demand for Injectable GLP-1 Drugs, Widens Gap with Novo

Reuters
·
Aug 05

Lilly Climbs on Annual Revenue Forecast Raise

Reuters
·
Aug 05

GUIDANCE: (LLY) Eli Lilly Expects 2026 Revenue Range $85B to $87B, vs. FactSet Est of $85.28B

MT Newswires Live
·
Aug 05

Eli Lilly Shares up 4.3% Premarket After Q2 Results Beat Estimates

THOMSON REUTERS
·
Aug 05